Načítá se...

DISPARITIES IN UPTAKE OF DIRECT-ACTING ANTIVIRAL THERAPY FOR HEPATITIS C AMONG PEOPLE WHO INJECT DRUGS IN A CANADIAN SETTING

BACKGROUND & AIMS: Despite the high burden of hepatitis C virus (HCV) infection among people who inject drugs (PWID), uptake of interferon-based therapies has been extremely low. Increasing availability of direct-acting antiviral (DAA)-based therapies offers the possibility of rapid treatment ex...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Liver Int
Hlavní autoři: Eugenia SOCÍAS, M., TI, Lianping, WOOD, Evan, NOSOVA, Ekaterina, HULL, Mark, HAYASHI, Kanna, DEBECK, Kora, Milloy, M-J
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6640076/
https://ncbi.nlm.nih.gov/pubmed/30653809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14043
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!